Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer

被引:79
作者
Kim, Michael Paul [1 ,2 ]
Zhang, Yun [2 ]
Lozano, Guillermina [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
关键词
mutant proteins; p53; mutation; gain of function; stroma; mouse models of cancer; TP53; cancer; GENE-EXPRESSION; STROMAL FIBROBLASTS; FUNCTION MUTATIONS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MOUSE MODELS; HUMAN BREAST; IN-VIVO; GAIN; CELLS;
D O I
10.3389/fonc.2015.00249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The functional importance of p53 as a tumor suppressor gene is evident through its pervasiveness in cancer biology. The p53 gene is the most commonly altered gene in human cancer; however, not all genetic alterations are biologically equivalent. The majority of alterations involve p53 missense mutations that result in the production of mutant p53 proteins. Such mutant p53 proteins lack normal p53 function and may concomitantly gain novel functions, often with deleterious effects. Here, we review characterized mechanisms of mutant p53 gain of function in various model systems. In addition, we review mutant p53 addiction as emerging evidence suggests that tumors may depend on sustained mutant p53 activity for continued growth. We also discuss the role of p53 in stromal elements and their contribution to tumor initiation and progression. Lastly, current genetic mouse models of mutant p53 in various organ systems are reviewed and their limitations discussed.
引用
收藏
页数:6
相关论文
共 50 条
[21]   A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells [J].
Okal, Abood ;
Mossalam, Mohanad ;
Matissek, Karina J. ;
Dixon, Andrew S. ;
Moos, Philip J. ;
Lim, Carol S. .
MOLECULAR PHARMACEUTICS, 2013, 10 (10) :3922-3933
[22]   YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins [J].
Di Agostino, Silvia ;
Sorrentino, Giovanni ;
Ingallina, Eleonora ;
Valenti, Fabio ;
Ferraiuolo, Maria ;
Bicciato, Silvio ;
Piazza, Silvano ;
Strano, Sabrina ;
Del Sal, Giannino ;
Blandino, Giovanni .
EMBO REPORTS, 2016, 17 (02) :188-201
[23]   Mutant p53 in cell-cell interactions [J].
Pilley, Steven ;
Rodriguez, Tristan A. ;
Vousden, Karen H. .
GENES & DEVELOPMENT, 2021, 35 (7-8) :433-448
[24]   Pharmacological targeting of mutant p53 [J].
Kogan, Samuel ;
Carpizo, Darren .
TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) :698-706
[25]   Gain of Function (GOF) Mutant p53 in Cancer-Current Therapeutic Approaches [J].
Roszkowska, Katarzyna A. ;
Piecuch, Aleksandra ;
Sady, Maria ;
Gajewski, Zdzislaw ;
Flis, Sylwia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[26]   Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer [J].
Zhang, Shengliang ;
Carlsen, Lindsey ;
Hernandez Borrero, Liz ;
Seyhan, Attila A. ;
Tian, Xiaobing ;
El-Deiry, Wafik S. .
BIOMOLECULES, 2022, 12 (04)
[27]   Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells [J].
Puca, R. ;
Nardinocchi, L. ;
Givol, D. ;
D'Orazi, G. .
ONCOGENE, 2010, 29 (31) :4378-4387
[28]   Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5 [J].
Vogiatzi, Fotini ;
Brandt, Dominique T. ;
Schneikert, Jean ;
Fuchs, Jeannette ;
Grikscheit, Katharina ;
Wanzel, Michael ;
Pavlakis, Evangelos ;
Charles, Jol P. ;
Timofeev, Oleg ;
Nist, Andrea ;
Mernberger, Marco ;
Kantelhardt, Eva J. ;
Siebolts, Udo ;
Bartel, Frank ;
Jacob, Ralf ;
Rath, Ariane ;
Moll, Roland ;
Grosse, Robert ;
Stiewe, Thorsten .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (52) :E8433-E8442
[29]   The multiple mechanisms that regulate p53 activity and cell fate [J].
Hafner, Antonina ;
Bulyk, Martha L. ;
Jambhekar, Ashwini ;
Lahav, Galit .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (04) :199-210
[30]   Mutant p53 reactivation by small molecules makes its way to the clinic [J].
Bykov, Vladimir J. N. ;
Wiman, Klas G. .
FEBS LETTERS, 2014, 588 (16) :2622-2627